LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,449 | -5.2% | 1,543 | +14.1% | 0.00% | – |
| Q2 2023 | $97,472 | -1.0% | 1,352 | +1.0% | 0.00% | – |
| Q1 2023 | $98,488 | +6.4% | 1,339 | -2.2% | 0.00% | – |
| Q4 2022 | $92,534 | -26.0% | 1,369 | -5.7% | 0.00% | – |
| Q3 2022 | $125,000 | -1.6% | 1,451 | +2.1% | 0.00% | – |
| Q2 2022 | $127,000 | -15.9% | 1,421 | +6.0% | 0.00% | – |
| Q1 2022 | $151,000 | -18.8% | 1,341 | +10.6% | 0.00% | – |
| Q4 2021 | $186,000 | +6.3% | 1,213 | -4.0% | 0.00% | – |
| Q3 2021 | $175,000 | 0.0% | 1,263 | -5.7% | 0.00% | – |
| Q2 2021 | $175,000 | -35.9% | 1,340 | -25.4% | 0.00% | -100.0% |
| Q1 2021 | $273,000 | +15.7% | 1,796 | -23.9% | 0.00% | 0.0% |
| Q4 2020 | $236,000 | -28.9% | 2,361 | -31.2% | 0.00% | 0.0% |
| Q3 2020 | $332,000 | -18.4% | 3,432 | -5.7% | 0.00% | 0.0% |
| Q2 2020 | $407,000 | +58.4% | 3,638 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $257,000 | – | 3,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |